Saag MS - Search Results

1

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.

Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 1998 Jul 1;280(1):78-86. doi: 10.1001/jama.280.1.78. JAMA. 1998. PMID: 9660368 Review.

2

Pathogenicity and diversity of HIV and implications for clinical management: a review.

Saag MS, Hammer SM, Lange JM. Saag MS, et al. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 2:S2-10; discussion S10-1. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7965648 Review.

3

Issues in combination antiretroviral therapy: a review.

Hammer SM, Kessler HA, Saag MS. Hammer SM, et al. Among authors: saag ms. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 2:S24-35; discussion S35-7. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7965649 Review.

4

HIV viral load markers in clinical practice.

Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. Saag MS, et al. Nat Med. 1996 Jun;2(6):625-9. doi: 10.1038/nm0696-625. Nat Med. 1996. PMID: 8640545 Review.

5

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Sáag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 1996 Jul 10;276(2):146-54. JAMA. 1996. PMID: 8656507 Review.

6

HIV-specific cellular and humoral immune responses in primary HIV infection.

Connick E, Marr DG, Zhang XQ, Clark SJ, Saag MS, Schooley RT, Curiel TJ. Connick E, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 1996 Aug 10;12(12):1129-40. doi: 10.1089/aid.1996.12.1129. AIDS Res Hum Retroviruses. 1996. PMID: 8844017

7

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 1997 Jun 25;277(24):1962-9. JAMA. 1997. PMID: 9200638

8

Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197.

Fischl MA, Richman DD, Saag M, Meng TC, Squires KE, Holden-Wiltse J, Meehan PM. Fischl MA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):247-53. doi: 10.1097/00042560-199712010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9402071 Clinical Trial.

9

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Marschner IC, et al. Among authors: saag ms. J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823. J Infect Dis. 1998. PMID: 9419168 Clinical Trial.

10

Antiretroviral chemotherapy.

Saag MS, Schooley RT. Saag MS, et al. Curr Clin Top Infect Dis. 1998;18:154-79. Curr Clin Top Infect Dis. 1998. PMID: 9779354 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page